2014
DOI: 10.1583/13-4401mr.1
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Collagen-Based Vascular Closure Devices in Patients With vs. Without Severe Peripheral Artery Disease

Abstract: Our study shows no significant differences in the rate of major complications after utilization of a collagen-based VCD for femoral artery access site closure in patients with severe lower limb PAD compared to those without; however, complications in the PAD group tended to be more severe, with the need for surgical repair.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 31 publications
0
11
1
Order By: Relevance
“…13 In our prospective study, we report comparable complication rates using collagen-based VCDs in patients with PAD when compared to VCDs in patients with coronary artery disease. In another series, major and minor complication rates were 1.7 and 6.7%, respectively, after the utilization of a collagen-based VCDs in patients with PAD 16 compared with 0 and 6.6% in our series. These results are comparable to those with CAD.…”
Section: Discussioncontrasting
confidence: 48%
“…13 In our prospective study, we report comparable complication rates using collagen-based VCDs in patients with PAD when compared to VCDs in patients with coronary artery disease. In another series, major and minor complication rates were 1.7 and 6.7%, respectively, after the utilization of a collagen-based VCDs in patients with PAD 16 compared with 0 and 6.6% in our series. These results are comparable to those with CAD.…”
Section: Discussioncontrasting
confidence: 48%
“…Their position change did not induce complications such as bleeding and hematoma in the femoral artery puncture area, but femoral arterial catheterization and the administration of an anticoagulant to prevent blood clotting could cause vascular complications such as bleeding, hematoma, and false aneurysm in the femoral arterial puncture site8, 10,11,12 ) . According to clinical guidelines13 ) , patients are moved to the ward with their catheters intact from the pathology laboratory to prevent bleeding or hematoma development.…”
Section: Introductionmentioning
confidence: 99%
“…It should be noted that the authors did not evaluate for disease at the access site. 17 Thus, these data do not alter our use of MC for hemostasis in these situations.…”
Section: Operators' Experiencementioning
confidence: 80%